SAM Companies Expands Central Texas Footprint with Acquisition of Inland Geodetics SAM Companies orwidely recognized as one of the nation’s most trusted and sought-after providers within the infrastructure ecosystem, today announced the acquisition of Inland Geodetics (“Inland”), a Texas-based land…
Tartar Shield Launches “Second Smile” Initiative to Boost Shelter Dog Health and Adoption Success More than 120 adoptable dogs at the Humane Society of Tampa Bay are set to benefit from an innovative new program designed to improve both their…
Brainlab and Precision NeuroMed Forge Strategic Partnership to Revolutionize AI-Driven Brain Therapy In a major leap forward for neurological care, Brainlab SE (Brainlab), a global leader in digital medical technology, and Precision NeuroMed (PNM), a clinical-stage biotechnology company pioneering precision…
Battelle Secures Sole Award for DTRA STEP 2.0 Contract to Advance Global Biological Threat Reduction Initiatives Battelle, a global leader in scientific research and national security solutions, has been awarded the Defense Threat Reduction Agency’s (DTRA) Scientific and Technical Engagement…
Investor Consortium Backs Graforce’s Plasma Pyrolysis Technology to Revolutionize Low-Carbon Industrial Fuels A strategic investment consortium composed of Paris-based next-generation fuels industrial and technology fund Calderion (Audacity), infrastructure developer Terravent, and WenCo Family Office has officially closed a significant double-digit…
Gilead Sciences Presents Positive Phase 3 ARTISTRY Trial Data for Investigational Bictegravir/Lenacapavir HIV Regimen at CROI 2026 Gilead Sciences, Inc. today shared compelling new data from its Phase 3 ARTISTRY-1 and ARTISTRY-2 clinical trials at the 33rd Conference on Retroviruses…
ViiV Healthcare highlights promising investigational treatments designed to deliver long-acting HIV control with just two doses per year, aiming to improve adherence and patient convenience. ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi…
Montrose Environmental Group reports record revenue, earnings, and cash flow for 2025, driven by strong demand across core environmental solutions, and increases its 2026 guidance on continued operational momentum. Montrose Environmental Group, Inc. delivered a standout performance in 2025, reporting…
Agilent Technologies, Inc. reports 7% revenue growth to $1.80 billion, highlighting strong core performance and operational momentum in the first quarter of fiscal 2026. Agilent Technologies, Inc. (NYSE: A) reported a solid start to fiscal 2026, delivering first-quarter revenue of…
Thermo Fisher Scientific Announces 10% Increase in Cash Payout, Strengthening Commitment to Shareholder Returns and Long-Term Growth Thermo Fisher Scientific Inc , widely recognized as the world leader in serving science, has announced that its Board of Directors has authorized…